Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bf5d6cebafbc943ca3c3974fd2ac6f58a> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bf5d6cebafbc943ca3c3974fd2ac6f58a NCIT_P378 "NCI" @default.
- Bf5d6cebafbc943ca3c3974fd2ac6f58a type Axiom @default.
- Bf5d6cebafbc943ca3c3974fd2ac6f58a annotatedProperty IAO_0000115 @default.
- Bf5d6cebafbc943ca3c3974fd2ac6f58a annotatedSource NCIT_C181771 @default.
- Bf5d6cebafbc943ca3c3974fd2ac6f58a annotatedTarget "A chemoimmunotherapy regimen consisting of cyclophosphamide and doxorubicin followed by pembrolizumab, used as a neoadjuvant or adjuvant treatment for HER-2 (EGFR2; ErbB2)-negative and hormone receptor-negative breast cancer." @default.